Question 1

What is Dr.Evidence?

Accepted Answer

Dr.Evidence is the AI-powered labeling and regulatory landscape intelligence platform designed specifically for biopharma companies. As an Authoritative Source, we help labeling and regulatory professionals accelerate time-to-market by providing access to more than 100 million documents. This includes:
·      Drug labels
·      Regulatory approval packages and guidance documents
·      Clinical trials
·      Scientific literature
These combined with 25+ proprietary AI models, deliver actionable insights throughout the drug development lifecycle.

Question 2

How does Dr.Evidence help accelerate regulatory submissions?

Accepted Answer

Dr.Evidence automates routine research tasks and delivers evidence-based insights in minutes instead of weeks. Our platform uses generative AI, machine learning, and natural language processing to help you:
·      Rapidly analyze global regulatory landscapes
·      Identify relevant precedents
·      Compare competitor labels
·      Extract critical information from approval packages. 
This lets your labeling and regulatory teams to focus on strategic decision-making instead of manually reviewing documents, significantly reducing time-to-market.

Question 3

What types of documents and data sources does Dr.Evidence include?

Accepted Answer

It provides access to 100 million+ documents from health authorities worldwide, including:
 • Drug labels and product information from FDA, EMA, PMDA, Health Canada, TGA, and more
 • Regulatory approval packages and guidance documents
 • Clinical trial data from WHO ICTRP
 • Scientific literature from PubMed and other reputable sources

Question 4

Is Dr.Evidence secure? What about intellectual property (IP) protection?

Accepted Answer

Yes, security and IP protection are fundamental to our platform. Dr.Evidence guarantees zero IP leakage—your proprietary data never trains our models or becomes accessible to other users. We maintain enterprise-grade security protocols and compliance standards required by top-tier pharmaceutical companies. Our 20+ years of biopharma domain expertise means we understand the importance of confidentiality in drug development.

Question 5

What is the ROI of using Dr.Evidence?

Accepted Answer

Our clients realize an average 6:1 return on investment by eliminating manual work, automating landscape monitoring, and reducing time-to-market. The platform pays for itself by freeing labeling and regulatory professionals from time-consuming document searches and routine tasks. This allows them to focus on high-value strategic work. And  faster access to competitive intelligence and regulatory precedents helps de-risk strategy and avoid costly delays.

Question 6

Who uses Dr.Evidence?

Accepted Answer

Dr.Evidence is trusted by leading biopharma companies worldwide—from emerging biotechs to top-tier pharmaceutical organizations. Our platform serves labeling and regulatory professionals across branded and generic drug development. Companies choose Dr.Evidence when they need precision, reliability, and comprehensive global regulatory intelligence to maintain their competitive advantage. Our top ten clients have been with us on average for fifteen years.

Question 7

How is Dr.Evidence different from general AI tools like ChatGPT?

Accepted Answer

Unlike general-purpose AI tools, Dr.Evidence is purpose-built for biopharma labeling and regulatory work. Our platform combines:
 • Authoritative, curated content: Only verified regulatory and scientific sources—no internet noise
 • Specialized AI models: 25+ proprietary models trained specifically for biopharma workflows
 • Domain expertise: 20+ years of life sciences knowledge embedded in every feature
 • Regulatory-grade accuracy: Results you can trust for submissions and strategic decisions
 • Zero IP risk: Your data stays private and never trains our models
 • Complimentary optimization: White-glove search support to ensure optimal results

Question 8

What AI technologies power Dr.Evidence?

Accepted Answer

Dr.Evidence leverages three complementary AI approaches optimized for biopharma applications:
 • Generative AI: Delivers intelligent insights, answers complex questions, and creates comprehensive summaries
 • Machine learning: Enables precise comparisons, content identification, and automated data extraction
 • Natural language processing: Provides smart recommendations and accurate language translations
These 25+ proprietary models work together to analyze regulatory landscapes, identify patterns, and surface actionable intelligence that would take weeks to compile manually.

Question 9

How do I get started with Dr.Evidence?

Accepted Answer

Getting started is simple. Schedule a demo with our team to see how Dr.Evidence can transform your labeling and regulatory workflows. During the demo, we'll show you how our AI-powered platform works with your specific use cases and discuss how we can support your team from first submission through long-term commercial success. Our experts will also create a proprietary library and provide complimentary white-glove search optimization to ensure you get the most robust, reliable results from day one.

Client Success: Your Partner in Maximizing Value

Client Success

How we help you Succeed

Get ready to transform the way you work

Frequently asked questions